Maraviroc-induced decrease in circulating bacterial products is not linked to an increase in immune activation in HIV-infected individuals
C. Psomas
(1)
,
Jp Lavigne
(2)
,
C. Barbuat
(2)
,
Saber Trabelsi
(2)
,
J. Ghosn
(2)
,
C. Lascoux-Combe
(2)
,
P. Flandre
(2)
,
L. Cuzin
(2)
,
J. Reynes
(2)
,
B. Autran
(2)
,
P. Corbeau
(1)